The record
A Johns Manville executive wrote privately in October 1974 that R. T. Vanderbilt Company talc products always had and continued to contain chrysotile as a significant component in addition to tremolite and anthophyllite, and that Vanderbilt's presentations to OSHA, NIOSH, FDA and MESA were “based on something less than the truth.”
Claim scope
A dated (October 11, 1974) intra-industry accusation that a named talc supplier was misrepresenting asbestos content to four federal agencies — recounted in a peer-reviewed PubMed-indexed paper. The paper also documents (January 18, 1973) an industry belief that the FDA “is reluctant to take any legal action in any problems with industry” and had “neither the money nor the manpower” to build airtight scientific cases.
What this source does not establish
This is one company's executive characterising a competitor, in private correspondence — not a finding by any agency or court that Vanderbilt misrepresented anything. R. T. Vanderbilt talc is the Gouverneur, New York industrial/cosmetic talc source and is NOT a J&J or Colgate source. Do not attach this to Johnson's Baby Powder.
Limitations
MANDATORY DISCLOSURE whenever this paper is cited: its own conflict-of-interest statement reads “David Rosner and Gerald Markowitz wrote a 2017 Report to the Court in a legal case that formed the original basis of this article. They received funding from plaintiffs' law firms for research and writing.” Its documentary base is litigation-discovery material hosted on toxicdocs.org. It is peer-reviewed and PubMed-indexed, which satisfies house citation standards, but it is not a neutral archival study. Attribute precisely: a Johns Manville executive's private assessment of a third company. Vanderbilt has its own extensive separate litigation history not examined on this track.
Source
Pmid — 31095409